331 related articles for article (PubMed ID: 24005839)
1. Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.
Cipriani P; Ruscitti P; Carubbi F; Pantano I; Liakouli V; Berardicurti O; Giacomelli R
Clin Rheumatol; 2014 Jan; 33(1):49-55. PubMed ID: 24005839
[TBL] [Abstract][Full Text] [Related]
2. Treatment of refractory adult onset Still's disease with tocilizumab-a single centre experience and literature review.
Reihl Crnogaj M; Čubelić D; Babić A; Mayer M; Anić B
Rheumatol Int; 2020 Aug; 40(8):1317-1325. PubMed ID: 32506202
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases.
Song ST; Kim JJ; Lee S; Kim HA; Lee EY; Shin KC; Lee JH; Lee KH; Choi ST; Cha HS; Yoo DH
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S64-S71. PubMed ID: 27462914
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review.
Sakai R; Nagasawa H; Nishi E; Okuyama A; Takei H; Kurasawa T; Kondo T; Nishimura K; Shirai Y; Ito T; Kameda H; Takeuchi T; Amano K
Clin Rheumatol; 2012 Mar; 31(3):569-74. PubMed ID: 22215118
[TBL] [Abstract][Full Text] [Related]
6. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
[TBL] [Abstract][Full Text] [Related]
7. Tocilizumab in adult-onset Still's disease: the Israeli experience.
Elkayam O; Jiries N; Dranitzki Z; Kivity S; Lidar M; Levy O; Ablin J; Abu-Shakra M; Savargyl-Maman H; Padova H; Caspi D; Rosner I
J Rheumatol; 2014 Feb; 41(2):244-7. PubMed ID: 24429168
[TBL] [Abstract][Full Text] [Related]
8. Tocilizumab in refractory adult Still's disease.
Puéchal X; DeBandt M; Berthelot JM; Breban M; Dubost JJ; Fain O; Kahn JE; Lequen L; Longy-Boursier M; Perdriger A; Schaeverbeke T; Toussirot E; Sibilia J;
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):155-9. PubMed ID: 20740616
[TBL] [Abstract][Full Text] [Related]
9. Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission.
Kobayashi D; Ito S; Murasawa A; Narita I; Nakazono K
Intern Med; 2015; 54(20):2675-9. PubMed ID: 26466710
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of tocilizumab in treating refractory adult-onset Still's disease with dichotomous phenotypes: IL-18 is a potential predictor of therapeutic response.
Tang KT; Hsieh CW; Chen HH; Chen YM; Chang SH; Huang PH; Lan JL; Chen DY
Clin Rheumatol; 2022 Feb; 41(2):557-566. PubMed ID: 34535869
[TBL] [Abstract][Full Text] [Related]
11. Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.
Bannai E; Yamashita H; Kaneko S; Ueda Y; Ozaki T; Tsuchiya H; Takahashi Y; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2016; 26(2):297-301. PubMed ID: 24697199
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry.
Sota J; Vitale A; Lopalco G; Pereira RMR; Giordano HF; Antonelli IPB; Makowska J; Brzezińska O; Lewandowska-Polak A; Ruscitti P; Cipriani P; Cola ID; Govoni M; Ruffili F; Sfikakis PP; Laskari K; Ragab G; Hussein MA; Gentileschi S; Gaggiano C; La Torre F; Maier A; Emmi G; Marino A; Ciccia F; Sfriso P; Maggio MC; Bartoloni E; Lomater C; Hegazy MT; Tektonidou M; Dagostin MA; Opinc A; Sebastiani GD; Giacomelli R; Giudice ED; Olivieri AN; Tufan A; Kardas RK; Nuzzolese R; Cardinale F; Więsik-Szewczyk E; Veronica P; Tarsia M; Iannone F; Della Casa F; Fabiani C; Frediani B; Balistreri A; Rigante D; Cantarini L
Semin Arthritis Rheum; 2022 Dec; 57():152089. PubMed ID: 36063578
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
Park EH; Lee EY; Shin K; Kim HA
Rheumatol Int; 2020 May; 40(5):791-798. PubMed ID: 31598752
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still's disease: A meta-analysis.
Ma Y; Wu M; Zhang X; Xia Q; Yang J; Xu S; Pan F
Mod Rheumatol; 2018 Sep; 28(5):849-857. PubMed ID: 29251027
[TBL] [Abstract][Full Text] [Related]
15. Adult-onset Still's disease: Advances in the treatment.
Castañeda S; Blanco R; González-Gay MA
Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):222-238. PubMed ID: 27886796
[TBL] [Abstract][Full Text] [Related]
16. Adult-onset still's disease and treatment results with tocilizumab.
Kır S; Özgen M; Zontul S
Int J Clin Pract; 2021 Mar; 75(3):e13936. PubMed ID: 33332679
[TBL] [Abstract][Full Text] [Related]
17. A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature.
Perdan-Pirkmajer K; Praprotnik S; Tomšič M
Clin Rheumatol; 2010 Dec; 29(12):1465-7. PubMed ID: 20734215
[TBL] [Abstract][Full Text] [Related]
18. Tocilizumab for the treatment of adult-onset Still's disease.
Castañeda S; Martínez-Quintanilla D; Martín-Varillas JL; García-Castañeda N; Atienza-Mateo B; González-Gay MA
Expert Opin Biol Ther; 2019 Apr; 19(4):273-286. PubMed ID: 30827128
[TBL] [Abstract][Full Text] [Related]
19. Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature.
Thonhofer R; Hiller M; Just H; Trummer M; Siegel C; Dejaco C
Rheumatol Int; 2011 Dec; 31(12):1653-6. PubMed ID: 21240503
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis and management of adult-onset Still's disease.
Efthimiou P; Georgy S
Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
